As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.
Subscribe to:
Post Comments (Atom)
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
No comments:
Post a Comment